TipRanks
Go Ultimate55% OFF

EyePoint Pharmaceuticals (PV3B) Cash flow

EyePoint Pharmaceuticals Cash Flow

DE:PV3B's free cash flow for Q2 2026 was $-63.55M. For the 2026 fiscal year, DE:PV3B's free cash flow was decreased by $-1.20M and operating cash flow was $-62.35M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
$ -240.11M$ -126.23M$ 1.88M$ -65.00M$ -50.10M
$ 68.58M$ -219.35M$ -3.31M$ -17.27M$ -33.12M
$ 173.65M$ 164.02M$ 187.07M$ -690.00K$ 216.90M
$ 101.97M$ 99.85M$ 281.26M$ 95.78M$ 178.74M
$ -243.39M$ -130.28M$ -1.61M$ -67.16M$ -50.25M

Currency in USD

EyePoint Pharmaceuticals Cash Flow

-300M-200M-100M0100M200M300M201720182019202020212022202320242025OperatingInvestingFinancing